Viral Warts Treatment Market Trends

Growth Drivers

• Advancements in treatment methodologies: This is the key factor reshaping the growth trajectory of the market since there have been continued innovations in terms of laser therapy, immunotherapy, and microwave treatments. In March 2024, Pulse Biosciences announced that it received FDA 510(k) acceptance for its CellFX nsPFA Percutaneous Electrode System, which precisely ablates soft tissue without thermal damage, offering a minimally invasive option for various surgical procedures.
• Research & development: The remarkable investments in developing novel therapies, including oral and combination treatments, are enhancing both efficacy and patient outcomes in this field. KI in March 2023 reported that a multi-country, five-year study funded by nearly USD 15 million from the Bill & Melinda Gates Foundation, with USD 1 million co-funding from the Swedish government, to understand the global burden of HPV among girls and women, which was led by the International Vaccine Institute in collaboration with Karolinska Institutet (KI) and other partners.
• Emergence of over-the-counter solutions: This is one of the principal drivers in this field since products such as salicylic acid, cryotherapy kits, and topical creams are becoming more popular, enabling convenient options for patients who prefer to manage their warts without visiting a healthcare professional. In May 2025, CryoConcepts, LP introduced the Skin Clinic, which is an FDA-cleared at-home cryotherapy solution skin tag remover designed for safe and effective skin tag removal, hence denoting a positive market outlook.

Key Statistics on Genital HPV Prevalence and Impact (Global, 2023 Study)

Source: WHO

Regulatory Developments in HPV Vaccines and Skin Wart Treatments

Source: Company Official Press Releases

Challenges

• Limited awareness: This is one of the major hindering factors in the market since the lack of proper awareness among patients about the condition and available treatment options restricts adoption. Also, many individuals hesitate to seek medical guidance due to the asymptomatic nature of warts or the social stigma associated with them. Therefore, this delay often leads to warts becoming extremely persistent, making treatment ultimately prolonged.
• Variability in treatment efficacy: This is another major factor affecting the progress of the viral warts treatment market since the current procedures can vary significantly in effectiveness depending on wart type, size, and patient immune response. Besides, even after the removal, warts can recur owing to the underlying human papillomavirus infection.  Hence, this unpredictability can lead to patient inconvenience and increased healthcare costs, posing a barrier to market growth.